Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients.

Antoine ParienteYohann MansiauxAna JarnéFrancesco SalvoCécile PageotJulien BezinAndy SmithBernard Bégaud

Published in: European journal of clinical pharmacology (2017)

If PW was accompanied with significant changes in the use of some antidiabetics, no adverse impact of PW on hospitalization or death rates of diabetic type 2 patients was found.

Keyphrases

end stage renal disease
healthcare
ejection fraction
newly diagnosed
public health
type diabetes
mental health
prognostic factors
transcription factor
emergency department
patient reported outcomes
risk assessment
wound healing
climate change